000			01972nam a22002297a 4500
001			D0001C000163
003			DOH
005			20210326111328.0
008			210326b ||||| |||| 00| 0 eng d
040			_erda
245	0	0	_aCOVID-19 rapid guideline : managing the long-term effects of COVID-19 _bmanaging the long-term effects of COVID-19
260			_aLondon : _bNational Institute for Health and Care Excellence, _c2020.
336			_2rdacontent _atext
337			_2rdamedia _aunmediated
338			_2rdacarier _avolume
520			_aThis guideline covers identifying, assessing and managing the long-term effects of COVID-19, often described as ‘long COVID’. It makes recommendations about care in all healthcare settings for adults, children and young people who have new or ongoing symptoms 4 weeks or more after the start of acute COVID-19. It also includes advice on organising services for long COVID. This guideline has been developed jointly by NICE, the Scottish Intercollegiate Guidelines Network (SIGN) and the Royal College of General Practitioners (RCGP). To develop the recommendations, we have used the following clinical definitions for the initial illness and long COVID at different times: Acute COVID-19: signs and symptoms of COVID-19 for up to 4 weeks. Ongoing symptomatic COVID-19: signs and symptoms of COVID-19 from 4 to 12 weeks. Post-COVID-19 syndrome: signs and symptoms that develop during or after an infection consistent with COVID-19, continue for more than 12 weeks and are not explained by an alternative diagnosis. When using this guideline, follow the usual professional guidelines, standards and laws (including those on equalities, safeguarding, communication and mental capacity), as described in making decisions using NICE guidelines.
600		2	_8COVID-19
600		2	_8Long Term Adverse Effects
600		2	_8Guideline
856			_uhttps://www.ncbi.nlm.nih.gov/books/NBK567261/
942			_2nlm _cCV
999			_c3788 _d3788